Stopping weight loss injections: regain, evidence and what helps

Why weight returns after stopping

Obesity is now understood as a chronic disease in which genes, hormones and environment regulate body weight. Blüher describes in Nature Reviews Endocrinology how the body pushes back after weight loss: hunger and appetite increase and energy use falls. Weight loss injections act on exactly this regulation, damping appetite and strengthening fullness while they work.

When they are stopped, this effect fades. Semaglutide has a half-life of about one week, as Marso and colleagues describe, so it is cleared over several weeks. Then the old appetite returns, often noticeably stronger than during treatment. This is biology, not personal failure, and it is why treatment is planned for the long term.

What the trials show

Trial	Design	After stopping	With continued treatment
STEP 4 (JAMA 2021)	20 weeks of semaglutide, then placebo or continue	plus 6.9 % over 48 weeks	a further minus 7.9 %
STEP 1 extension (2022)	68 weeks of semaglutide (minus 17.3 %), then one year off treatment	two thirds regained, net minus 5.6 %	not studied
SURMOUNT-4 (JAMA 2024)	36 weeks of tirzepatide (minus 20.9 %), then placebo or continue	plus 14.0 % over 52 weeks	a further minus 5.5 %

The STEP 1 extension with 327 participants also showed that improvements in blood pressure, blood sugar and lipids moved back towards baseline for most measures after stopping. The health benefit therefore depends closely on weight staying lower. Conversely, STEP 5 shows the effect remains stable over two years while treatment continues.

A worked example from the trial figures

Percentages are abstract. Using the SURMOUNT-4 averages, purely as an illustration: someone weighing 100 kilograms who loses 20.9 per cent over 36 weeks of tirzepatide weighs about 79 kilograms. If they stop and behave like the placebo group, they regain about 14 per cent over the next 52 weeks and end at about 90 kilograms. With continued treatment they would weigh about 75 kilograms after the same period.

Good reasons to stop

Stopping is right or necessary in some situations: a planned or actual pregnancy (semaglutide is stopped at least two months before a planned pregnancy according to the product information; tirzepatide has its own guidance), severe or persistent side effects, warning signs such as pancreatitis and a lack of response. Anyone who has lost less than 5 per cent after three to four months on the maintenance dose is unlikely to benefit much. Personal reasons such as cost are legitimate too. What matters is planning the stop rather than ending abruptly.

Planning to stop

A planned stop begins months ahead. Use the time on treatment to build habits that carry on without it: regular meals rich in protein and vegetables, few sugary drinks, movement on most days and strength training two to three times a week. Many doctors reduce the dose step by step rather than stopping abruptly, which helps track appetite and weight. To be honest, the cited sources contain no large trials showing that tapering prevents regain.

In the first weeks after the last injection, digestive symptoms usually ease while hunger returns, often faster than expected. Anyone taking blood pressure or diabetes medicines should measure more often, because doses reduced during treatment may need adjusting again. Agree with the doctor how often to weigh yourself, at what gain to get in touch and which options then exist, from intensified diet and exercise to renewed drug treatment or, with a very high BMI, advice on other procedures according to the S3 guideline.

Keeping the weight off

What helps most is unsurprising yet decisive: a protein-focused, energy-aware diet that fits daily life, regular exercise, enough sleep and stress management. Untreated conditions such as sleep apnoea, depression or an underactive thyroid make any weight goal harder. A realistic aim is to keep most of the success and above all the health benefits; even 5 per cent less weight measurably improves blood pressure, blood sugar and joints. Renewed treatment is possible and is part of managing a chronic disease. More on the medicines in Wegovy and Mounjaro; the overview is in Weight loss injections.

When you need urgent medical help

Call 112 for chest pain, shortness of breath, paralysis or speech problems and for severe upper abdominal pain radiating to the back. People with type 2 diabetes should check blood sugar closely after stopping; for very high values with strong thirst and tiredness outside surgery hours, call the German on-call medical service on 116 117. With a severe low mood or thoughts of self-harm, seek help immediately, for example from the German crisis line on 0800 111 0 111.